/PRNewswire/ Includes latest data for REGN5458, including in highest dose levels (200-800 mg) Among patients who responded across all dose groups (3-800.
New Treatments for Lymphoma, Leukemia Unveiled at Cancer Conference
Written by Jamie Reno on December 11, 2020 Fact checked by Jennifer Chesak
Encouraging news on cancer treatments such as CAR-T therapy and monoclonal antibodies was announced at an annual conference. Luis Alvarez/Getty Images
Updates on treatments for blood cancers such as leukemia and lymphoma were presented at the annual conference of the American Society of Hematology.
Scientists reported on further advancements in CAR-T therapies that boost a person’s immune system to fight cancers.
There were also reports of promising results of drugs known as monoclonal antibodies.
Every December, the American Society of Hematology (ASH) holds its Annual Meeting and Exposition.